Skip to main content

1-20 of 211 results for subject:Prices

Legislation X
Health Service Medical Supplies (Costs) Bill 2016-17

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

More
Health Service Medical Supplies (Costs) Bill 2016-17 (211)

Subject

More

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

Lords consideration of Commons amendments. Lords amendment not insisted on, and Commons amendments in lieu agreed to.

Lead member
Lord O'Shaughnessy
Department
Department of Health
Type
Debates on bills
Date
26 April 2017
Reference
782 cc1393-8
House
House of Lords

Moved by

Lord O'Shaughnessy

Member
Lord O'Shaughnessy (Conservative)
Type
Proceeding contributions
Date
26 April 2017
Reference
782 c1393
House
House of Lords

My Lords, I beg to move Motion A. In doing so, I apologise to the House for the late change to the running order. Noble Lords who were expecting—or indeed hoping—that my noble friend Lord Nash would be taking the Bill through will have to make do with me.

We are...

Member
Lord O'Shaughnessy (Conservative)
Type
Proceeding contributions
Date
26 April 2017
Reference
782 cc1393-5
House
House of Lords

My Lords, I am grateful to the Minister for the further thought that he has given to the amendment that your Lordships passed at an earlier stage. I am also grateful to him for his courtesy in showing me the amendments before he went forward with them; I very much...

Member
Lord Warner (Crossbench)
Type
Proceeding contributions
Date
26 April 2017
Reference
782 c1395
House
House of Lords

My Lords, I am glad that my noble friend is on the Front Bench to see this Bill safely through. I share with colleagues an appreciation of how he and officials from the department have worked consensually, carefully and considerately to try to make the Bill as good as we...

Member
Lord Lansley (Conservative)
Type
Proceeding contributions
Date
26 April 2017
Reference
782 cc1395-6
House
House of Lords

My Lords, I congratulate the Minister on his hard work on the Bill and his helpfulness. I have one question. As this is a global matter, how can the Government assure us that the prices of drugs will come down?

Member
Baroness Masham of Ilton (Crossbench)
Type
Proceeding contributions
Date
26 April 2017
Reference
782 c1396
House
House of Lords

My Lords, I look forward to the Minister’s answer to that last question. From the opposition Benches, I very much welcome the agreed amendment that has come forward from the Government today. It is good to see how wash-up can concentrate minds no end, and we have reached a very...

Member
Lord Hunt of Kings Heath (Labour)
Type
Proceeding contributions
Date
26 April 2017
Reference
782 cc1396-7
House
House of Lords

My Lords, I thank all noble Lords for their warm words and I reciprocate those feelings: it has been a very interesting, challenging and enjoyable experience working with noble Lords on this Bill on what is—as the noble Lord, Lord Hunt, has pointed out—a critical matter. It is not just...

Member
Lord O'Shaughnessy (Conservative)
Type
Proceeding contributions
Date
26 April 2017
Reference
782 cc1397-8
House
House of Lords

My Lords, I will not comment on that last remark. The key clause is Clause 5. Can I take it that once the Bill receives Royal Assent the Government can implement that straightaway?

Member
Lord Hunt of Kings Heath (Labour)
Type
Proceeding contributions
Date
26 April 2017
Reference
782 c1398
House
House of Lords

I believe that would be the case. Of course, there is a difference between what officials can do and what Ministers can give instructions to do in a period of purdah. However, as soon as the measure is in law, it is enforceable.

Member
Lord O'Shaughnessy (Conservative)
Type
Proceeding contributions
Date
26 April 2017
Reference
782 c1398
House
House of Lords

Moved by

Lord O'Shaughnessy

Member
Lord O'Shaughnessy (Conservative)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 c1059
House
House of Lords

My Lords, before I address the specifics of the Motion I would like to remind the House of the wider policy context in which this Bill sits. In their approach to medicines and the life sciences industry, the Government have three objectives: to make sure that patients have access to...

Member
Lord O'Shaughnessy (Conservative)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 cc1059-1063
House
House of Lords

Moved by

Lord Warner

Member
Lord Warner (Crossbench)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 c1060
House
House of Lords

My Lords, the amendment removes the requirement on the Government in the original amendment passed by this House to have “full regard” to the considerations relating to life sciences and access to NICE-approved medicines and treatments. Instead, it requires the Government to “take account of” those considerations in discharging its...

Member
Lord Warner (Crossbench)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 cc1060-5
House
House of Lords

My Lords, I support the noble Lord, Lord Warner, in his amendment. I thank the Minister for how he has worked with your Lordships’ House on all sides to improve this Bill; it is unfortunate that we remain with one point of disagreement. We certainly support the policy objective of...

Member
Baroness Walmsley (Liberal Democrat)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 cc1065-6
House
House of Lords

My Lords, I intervene in this instance not to agree with but, I am afraid, to disagree with the amendment in the name of the noble Lord, Lord Warner. However, I will also make some important points that are relevant to the issues raised in this Motion and the amendment.

I...

Member
Lord Lansley (Conservative)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 cc1066-7
House
House of Lords

Perhaps I may just ask the Minister to explain how, under the PPRS, incentives are often given through R&D tax allowances. Does he not consider that state aid?

Member
Lord Warner (Crossbench)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 c1067
House
House of Lords

I am perfectly happy if the Minister wants to reply but, from my point of view, I do not regard the PPRS as state aid. If R&D tax credits are available, they should be made available. When the Office of Fair Trading reviewed the PPRS back in 2008-09, I think,...

Member
Lord Lansley (Conservative)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 cc1067-8
House
House of Lords

My Lords, I thank the Minister for the way in which he has conducted all the previous stages of the Bill, the amount of discussion and negotiation that he has had with all of us, and for accepting many of the amendments. It might be helpful to the House, if,...

Member
Baroness Finlay of Llandaff (Crossbench)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 cc1068-9
House
House of Lords

My Lords, I am all in favour of bringing down the price of drugs where possible, but patients’ access to new drugs is very important. For a long time, NICE has been very slow to approve drugs and that has caused great frustration for patients and the industry. What can...

Member
Baroness Masham of Ilton (Crossbench)
Type
Proceeding contributions
Date
5 April 2017
Reference
782 c1069
House
House of Lords